Cambrian BioPharma
Latest round
- Series C
Last raised
- Oct 2021
Total raised
- $125M
Investors
- 9
About Cambrian BioPharma
Based in New York, US, and founded in 2019 by its CEO, James Peyer, and founders Christian Angermayer and Sebastian Brunemeier, Cambrian BioPharma, Inc. As of 2021, Cambrian has 14 new drugs in progress across its portfolio of businesses. In October 2021, Cambrian BioPharma, Inc. The Cambrian BioPharma platform advances treatments and medications to reduce and treat age-related illnesses such as heart disease, cancer, and dementia, allowing scientists to transfer findings from the lab to the clinic and deliver medicines to patients in need.
Who invested in Cambrian BioPharma
9 investors across 3 rounds
See all investors in Cambrian BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cambrian BioPharma
Who invested in Cambrian BioPharma?
Cambrian BioPharma has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cambrian BioPharma raised?
Cambrian BioPharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cambrian BioPharma last raise money?
Cambrian BioPharma's most recent round on record is a Series C, in Oct 2021.
What does Cambrian BioPharma do?
Based in New York, US, and founded in 2019 by its CEO, James Peyer, and founders Christian Angermayer and Sebastian Brunemeier, Cambrian BioPharma, Inc.
Where is Cambrian BioPharma headquartered?
Cambrian BioPharma is headquartered in New York, US.
Which VCs invest in companies like Cambrian BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cambrian BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Cambrian BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.